ASCP: American Society of Clinical Psychopharmacology
Conference Coverage
Severity of side effects key to choosing between lithium and quetiapine in bipolar I and II
Key clinical point: Determining whether to use lithium or quetiapine in bipolar I and II comes down to side effects.Major finding: No clinically...
Conference Coverage
ADHD drug works by stimulating brain’s motivation-reward system
Key clinical point: Patients with ADHD who are taking lisdexamfetamine dimesylate "don’t need as much reward in order to get them to engage in an...
Conference Coverage
Dissociation found to mediate ketamine’s antidepressive effects
Key clinical point: Some degree of dissociation might be needed "as a proxy for the strength of the NMDA receptor blockade because of its...
Conference Coverage
Lurasidone monotherapy improves quality of life in bipolar I
Key clinical point: Lurasidone appears to reduce depressive symptoms in patients with bipolar I depression without the metabolic complications...
News
Novel intervention improves outcomes in homeless schizophrenia patients
Major finding: Homeless patients with schizophrenia missed 46% of their oral medication in the month prior to a customized psychosocial...
News
Levomilnacipran SR for major depression also improves attention deficits
Major finding: Patients with severe major depressive disorder who had a significant clinical response to the investigational antidepressant...
News
Two antipsychotic switching strategies yield different early results
Major finding: Patients with schizophrenia who discontinued risperidone, olanzapine, or aripiprazole and started on iloperidone the following day...
News
Novel antipsychotic shows early promise
Major Finding: Forty-five percent of patients with schizophrenia or schizoaffective disorder randomized to RP5063 responded with at least a 2-...
News
Lurasidone shows efficacy in bipolar depression
Major finding: Patients with bipolar I depression responded to 6 weeks of lurasidone at either a lower or higher dose range with identical 15.4-...
News
Selegiline transdermal system promising for social phobia
Major finding: Patients with social phobia showed significant improvement on multiple efficacy measures in response to treatment with the...
News
Novel intranasal antidepressant shows results after 1 week
Major finding: A self-administered intranasal spray antidepressant resulted in a mean 10.1-point reduction in scores on the Hamilton Rating Scale...